CalciMedica Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . CalciMedica Common Stock
CALC Stock   5.78  0.07  1.23%   
CalciMedica Common's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CalciMedica Common's valuation are provided below:
Market Capitalization
83.3 M
Earnings Share
(1.62)
We have found one hundred twenty available fundamental signals for CalciMedica Common Stock, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of CalciMedica Common's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 37.6 M, whereas Enterprise Value is forecasted to decline to about 34.1 M.
Check CalciMedica Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CalciMedica Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 49.6 K, Selling General Administrative of 12 M or Other Operating Expenses of 23.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.61. CalciMedica financial statements analysis is a perfect complement when working with CalciMedica Common Valuation or Volatility modules.
  
Build AI portfolio with CalciMedica Stock
Check out the analysis of CalciMedica Common Correlation against competitors.

CalciMedica Common Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets30.2 M17.8 M26.8 M
Pretty Stable
Short and Long Term Debt Total4.6 M4.8 M51.6 M
Slightly volatile
Other Current Liabilities2.8 M1.5 M3.3 M
Pretty Stable
Total Current Liabilities4.8 M3.3 M5.6 M
Slightly volatile
Property Plant And Equipment Net101.7 K107.1 K1.2 M
Slightly volatile
Accounts Payable1.9 M1.8 M2.4 M
Slightly volatile
Cash10.3 M7.1 M12.4 M
Pretty Stable
Non Current Assets Total110.3 K116.1 K3 M
Slightly volatile
Non Currrent Assets Other8.6 K9 K1.8 M
Slightly volatile
Cash And Short Term Investments27.3 M16.8 M22.7 M
Pretty Stable
Common Stock Shares Outstanding13.6 M12.9 M3.2 M
Slightly volatile
Liabilities And Stockholders Equity30.2 M17.8 M26.8 M
Pretty Stable
Other Current Assets1.2 M896.4 K1 M
Pretty Stable
Other Stockholder Equity131.4 M200.3 M69.6 M
Slightly volatile
Total Liabilities5.8 M4.8 M6.4 M
Very volatile
Total Current Assets28.5 M17.7 M23.7 M
Pretty Stable
Common Stock4.8 K4.6 K1.7 K
Slightly volatile
Short Term Investments9.2 M9.7 M21.8 M
Very volatile
Property Plant And Equipment Gross101.7 K107.1 K1.9 M
Slightly volatile
Capital Stock3.4 K3.6 K77.3 M
Slightly volatile
Net Working Capital13.7 M14.4 M28.4 M
Very volatile
Current Deferred Revenue1.2 M1.2 M340 K
Slightly volatile
Net Receivables33 K44.9 K26.3 K
Slightly volatile
Other Liabilities10.5 M11.8 M12.9 M
Slightly volatile
Long Term Debt4.1 M4.6 M5.1 M
Slightly volatile
Deferred Long Term Liabilities1.1 M1.3 M1.4 M
Slightly volatile
Property Plant Equipment156 K175.5 K191.6 K
Slightly volatile

CalciMedica Common Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization49.6 K52.2 K180.1 K
Pretty Stable
Selling General Administrative12 M11.2 M8.5 M
Slightly volatile
Other Operating Expenses23.8 M21.8 M28.4 M
Pretty Stable
Research Development15.1 M13 M20.2 M
Slightly volatile
Cost Of Revenue49.6 K52.2 K180.1 K
Pretty Stable
Total Operating Expenses23.8 M21.8 M28.4 M
Pretty Stable
Interest Income340.2 K661.2 K407.4 K
Pretty Stable
Reconciled Depreciation49.6 K52.2 K264.7 K
Slightly volatile
Interest Expense102.2 K99 K132.5 K
Slightly volatile

CalciMedica Common Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.8 M2.7 M2 M
Slightly volatile
Begin Period Cash Flow8.5 M5 M5.4 M
Slightly volatile
Depreciation49.6 K52.2 K180.1 K
Pretty Stable
Capital Expenditures6.8 K7.2 K904.1 K
Slightly volatile
Total Cash From Financing Activities28.2 M25.2 M37.5 M
Slightly volatile
End Period Cash Flow10.3 M7.1 M12.4 M
Pretty Stable
Issuance Of Capital Stock28.9 M25.2 M44.9 M
Slightly volatile
Change To Netincome2.7 M1.9 M3.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Book Value Per Share1.41.4725.0896
Very volatile
Capex To Depreciation0.120.13797.3938
Pretty Stable
Payables Turnover0.03170.03340.1168
Very volatile
Cash Per Share1.811.9126.2344
Very volatile
Days Payables Outstanding6.3 K11.3 K6.8 K
Slightly volatile
Income Quality0.991.391.1183
Slightly volatile
Current Ratio7.016.144.4878
Slightly volatile
Tangible Book Value Per Share1.41.4725.0896
Very volatile
Capex Per Share8.0E-48.0E-41.1704
Slightly volatile
Graham Net Net1.291.3620.6438
Very volatile
Interest Debt Per Share0.02680.028256.3885
Slightly volatile
Debt To Assets0.150.162.5903
Slightly volatile
Days Of Payables Outstanding6.3 K11.3 K6.8 K
Slightly volatile
Ebt Per Ebit1.030.650.9538
Pretty Stable
Quick Ratio7.016.144.4886
Slightly volatile
Net Income Per E B T3.644.14.4707
Slightly volatile
Cash Ratio2.952.482.4634
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.131.151.0538
Pretty Stable
Debt Ratio0.150.162.5903
Slightly volatile

CalciMedica Common Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37.6 M35.8 M13.2 M
Slightly volatile

CalciMedica Fundamental Market Drivers

CalciMedica Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About CalciMedica Common Financial Statements

CalciMedica Common stakeholders use historical fundamental indicators, such as CalciMedica Common's revenue or net income, to determine how well the company is positioned to perform in the future. Although CalciMedica Common investors may analyze each financial statement separately, they are all interrelated. For example, changes in CalciMedica Common's assets and liabilities are reflected in the revenues and expenses on CalciMedica Common's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CalciMedica Common Stock. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.2 M1.2 M
Cost Of Revenue52.2 K49.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc
When determining whether CalciMedica Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica Common Stock Stock:
How To Invest In CalciMedica
Details
Is CalciMedica Stock a good investment?
Details
What is CalciMedica Common's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of CalciMedica Common Correlation against competitors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica Common. If investors know CalciMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.62)
Return On Assets
(1.00)
Return On Equity
(5.26)
The market value of CalciMedica Common Stock is measured differently than its book value, which is the value of CalciMedica that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica Common's market value can be influenced by many factors that don't directly affect CalciMedica Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between CalciMedica Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY